Table 3 MRI staging of patients with COVID-19-associated mucormycosis
From: Imaging of COVID-19-associated rhino-orbital-cerebral mucormycosis: imaging analysis of 120 patients
Staging | Site of involvement | Number of patients (percentage) |
|---|---|---|
Stage I | Involvement of the nose and paranasal sinuses with no extra-sinus extension | 29 (24.17%) |
Stage II | Extra-sinus maxillo-facial extension | 7 (5.83%) |
Stage III | Extra-sinus maxillofacial and orbital extension with no intracranial involvement | 60 (50.00%) |
Stage IV | Intracranial extension | 24 (20.00%) |